Position in JNJ
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$8,870,410
+$1,069,841 QoQ
Shares Held
34,927
+9.4% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.25%
of 13F equity value
Holder Rank
#1,185
of 4,676 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 51%
Shared 0%
None 49%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Dana Investment Advisors, Inc. holds $103,613,510 across 8 Drug Manufacturers - General names. JNJ ranks #3 (8.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
35,592 | $42,690,116 | |
| 2 | ABBV |
AbbVie Inc.
|
157,662 | $39,674,065 | |
| 3 | JNJ |
Johnson & Johnson
This page
|
34,927 | $8,870,410 | |
| 4 | MRK |
Merck & Co., Inc.
|
48,543 | $6,237,775 | |
| 5 | BMY |
Bristol Myers Squibb Co
|
44,825 | $2,582,816 | |
| 6 | PFE |
Pfizer Inc
|
75,072 | $1,807,733 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
9,640 | $1,217,917 | |
| 8 | AMGN |
Amgen Inc
|
1,471 | $532,678 |
All Filings in JNJ
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $8,870,410 | 34,927 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $7,800,569 | 31,912 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $6,500,920 | 31,413 | Shares | Sole | 2026-02-05 | |
| 2025-09-30 | $5,832,756 | 31,457 | Shares | Sole | 2025-11-10 | |
| 2025-06-30 | $5,310,048 | 34,763 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $5,633,418 | 33,969 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $4,905,221 | 33,918 | Shares | Sole | 2025-02-06 | |
| 2024-09-30 | $6,162,817 | 38,028 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $6,979,286 | 47,751 | Shares | Sole | 2024-08-27 | |
| 2024-03-31 | $7,604,193 | 48,070 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $8,217,721 | 52,429 | Shares | Sole | 2024-02-07 | |
| 2023-09-30 | $16,572,267 | 106,403 | Shares | Sole | 2023-11-15 | |
| 2023-06-30 | $7,813,206 | 47,204 | Shares | Sole | 2023-08-15 | |
| 2023-03-31 | $7,161,775 | 46,205 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $9,101,361 | 51,522 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $8,474,626 | 51,877 | Shares | Sole | 2022-11-15 | |
| 2022-06-30 | $9,389,746 | 52,897 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $3,902,072 | 22,017 | Shares | Sole | 2022-05-12 | |
| 2021-12-31 | $3,709,139 | 21,682 | Shares | Sole | 2022-02-09 | |
| 2021-09-30 | $3,973,869 | 24,606 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $4,022,950 | 24,420 | Shares | Sole | 2021-08-10 | |
| 2021-03-31 | $3,588,910 | 21,837 | Shares | Sole | 2021-05-13 | |
| 2020-12-31 | $3,737,145 | 23,746 | Shares | Sole | 2021-02-11 | |
| 2020-09-30 | $4,491,411 | 30,168 | Shares | Sole | 2020-11-10 | |
| 2020-06-30 | $4,231,556 | 30,090 | Shares | Sole | 2020-08-11 | |
| 2020-03-31 | $4,111,187 | 31,352 | Shares | Sole | 2020-05-13 | |
| No filing history on record for this holder in this stock. | ||||||